ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Editorial   
  • J Biotechnol Biomater 2023, Vol 13(5): 350
  • DOI: 10.4172/2155-952X.1000350

Laboratory to Bedside: Biotechnology's Place in Healthcare's Transformational Development Environment

Lianjie Miao*
Renaissance Diacare, Creative Biosciences Co. Ltd., Guangzhou, China
*Corresponding Author : Lianjie Miao, Renaissance Diacare, Creative Biosciences Co. Ltd., Guangzhou, China, Email: Lianjiemiao54@gmail.com

Received Date: Sep 02, 2023 / Accepted Date: Sep 28, 2023 / Published Date: Sep 29, 2023

Abstract

The current state of healthcare is shifting due to the fast developing field of biotechnology, which has the potential to revolutionize how illnesses are identified and treated. Healthcare biotechnology has been the topic of many great efforts, and our understanding of it has grown significantly. New biomedical paradigms are developing as a result of the most recent developments in genetics and molecular biology, igniting fresh research into brandnew solutions for human health and wellbeing. However, an exciting obstacle still exists in the practical translational development of revolutionary technological discoveries. Only a small number of biotech breakthroughs have led to brand-new, revolutionary treatments and technologies for healthcare. We shall describe the clinical translational development atmosphere for biotechnology in healthcare in this paper. Notable medical biotechnology achievements and translational promotions, including historical findings and novel perspectives are carefully covered. More groundbreaking biotech ideas are about to be translated into commercial products to bring about positive health gains, despite the fact that there are nevertheless numerous obstacles in the bench-to-bedside translational development process. This is being carried out with a tight multitude of collaboration among research institutes, healthcare providers, and industry partners.

Citation: Miao L (2023) Laboratory to Bedside: Biotechnology's Place in Healthcare's Transformational Development Environment. J Biotechnol Biomater, 13: 350. Doi: 10.4172/2155-952X.1000350

Copyright: © 2023 Miao L. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top